Melatonin protects female rats against steatosis and liver oxidative stress induced by oestrogen deficiency

Life Sciences

Volumn 157, Issue , 2016, Pages 178-186

  Hermoso, Danielle Aparecida Munhos ^a   Shimada, Lilian Brites Campos ^a,c   Gilglioni, Eduardo Hideo ^a   Constantin, Jorgete ^a   Mito, Márcio Shigueaki ^a   Hermoso, Aparecida Pinto Munhos ^a   Salgueiro Pagadigorria, Clairce Luzia ^b   Iwamoto, Emy Luiza Ishii ^a  

^a Laboratory of Biological Oxidations   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

^c Centro Educacional Integrado   (Brazil)

Author keywords

Melatonin; Obesity; Ovariectomy; Steatosis

Indexed keywords

GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID; MALONALDEHYDE; MELATONIN; REACTIVE OXYGEN METABOLITE; ESTROGEN; FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOSOL; DRUG MECHANISM; ENZYME ACTIVITY; ESTROGEN DEFICIENCY; FATTY ACID OXIDATION; FATTY LIVER; FEMALE; LIPID LIVER LEVEL; LIPID STORAGE; LIVER HOMOGENATE; LIVER PROTECTION; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN CONTENT; RAT; WEIGHT GAIN; ANIMAL; BLOOD; DEFICIENCY; DRUG EFFECTS; LIVER; LIVER MITOCHONDRION; METABOLISM; OXIDATION REDUCTION REACTION; WISTAR RAT;

ANIMALS; ESTROGENS; FATTY ACIDS; FATTY LIVER; FEMALE; LIPIDS; LIVER; MELATONIN; MITOCHONDRIA, LIVER; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 84975748961     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.05.044     Document Type: Article

References (66)

1. [1] Pandi-Perumal, S.R., Sinivasan, V., Maestroni, G.J.M., Cardinali, D.P., Poeggeler, B., Hardeland, R., Melatonin. Nature's most versatile biological signal?. FEBS J. 273 (2006), 2813–2838.
2. [2] Reiter, R.J., Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12 (1991), 151–180.
3. [3] Pandi-Perumal, S.R., Trakht, I., Srinivasan, V., Spence, D.W., Maestroni, G.J.M., Zisapel, N., Cardinali, D.P., Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog. Neurobiol. 85 (2008), 335–353.
4. [4] Carpentieri, A., Barboza, G.D., Areco, V., López, M.P., de Talamoni, N.T., New perspectives in melatonin uses. Pharmacol. Res. 65 (2012), 437–444.
5. [5] Acuña-Castroviejo, D., Escames, G., Venegas, C., Díaz-Casado, M.E., Lima-Cabello, E., López, L.C., Rosales-Corral, S., Tan, D.X., Reiter, R.R., Extrapineal melatonin: sources, regulation, and potential function. Cell. Mol. Life Sci. 71 (2014), 2997–3025.
6. [6] Reiter, R.J., Tan, D.X., Fuentes-Broto, L., Melatonin: a multitasking molecule. Prog. Brain Res. 181 (2010), 127–151.
7. [7] Reiter, R.J., Tan, D.X., Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc. Res. 58 (2003), 10–19.
8. [8] Reiter, R.J., Manchester, L.C., Tan, D.X., Neurotoxins: free radical mechanisms and melatonin protection. Curr. Neuropharmacol. 8 (2010), 194–210.
9. [9] De Berardis, D., Marini, S., Fornaro, M., Srinivasan, V., Iasevoli, F., Tomasetti, C., Valchera, A., Perna, G., Quera-Salva, M.A., Martinotti, G., di Giannantonio, M., The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice. Int. J. Mol. Sci. 14 (2013), 12458–12483.
10. [10] Tosini, G., Baba, K., Hwang, C.K., Luvone, P.M., Melatonin: an underappreciated player in retinal physiology and pathophysiology. Exp. Eye Res. 103 (2012), 82–89.
11. [11] Jahnke, G., Marr, M., Myers, C., Wilson, R., Travlos, G., Price, C., Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol. Sci. 50 (1999), 271–279.
12. [12] Ersahin, M., Özdemir, Z., Özsavc, D., Akakin, D., Yeğen, B., Reiter, R.J., Sener, G., Melatonin treatment protects against spinal cord injury induced functional and biochemical changes in rat urinary bladder. J. Pineal Res. 52 (2012), 340–348.
13. [13] Shirazi, A., Mihandoost, E., Ghobadi, G., Mohsenni, M., Ghazi-Khansari, M., Evaluation of radio-protective effect of melatonin on whole body irradiation induced liver damage. Cell J. 14 (2013), 292–297.
14. [14] Favero, G., Rodella, L.F., Reiter, R.J., Rezzani, R., Melatonin and its atheroprotective effects: a review. Mol. Cell. Endocrinol. 382 (2014), 926–937.
15. [15] Celinski, K., Konurek, P.C., Slomka, M., Cichoz-Lach, H., Brzozowski, T., Kounturek, S.J., Korolczuk, A., Effects of treatment with melatonin and tryptophan on liver enzymes, parametrs of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease – 14 months follow up. J. Physiol. Pharmacol. 65 (2014), 75–82.
16. [16] Hussein, M.R., Ahmed, O.G., Hassan, A.F., Ahmed, M.A., Intake of melatonin is associated with amelioration of physiological changes, both metabolic and morphological pathologies associated with obesity: an animal model. Int. J. Exp. Pathol. 88 (2007), 19–29.
17. [17] Hatzis, G., Ziakas, P., Kavantzas, N., Triantafyllou, A., Sigalas, P., Andreadou, I., Ionnidis, K., Chatzis, S., Filis, K., Papalampros, A., Sigala, F., Melatonin attenuates high fat diet-induced fatty liver disease in rats. World J. Hepatol. 27 (2013), 160–169.
18. [18] Prunet-Marcassus, B., Desbazeille, M., Bros, A., Louche, K., Delagrande, P., Renard, P., Casteilla, L., Pénicaud, L., Melatonin reduces body weight gain in Sprague-Dawley rats with diet-induced obesity. Endocrinology 144 (2003), 5347–5352.
19. [19] Cagnacci, A., Arangino, S., Angiolucci, M., Melis, G.B., Tarquini, R., Renzi, A., Volpe, A., Different circulatory response to melatonin in postmenopausal women without and with hormone replacement therapy. J. Pineal Res. 29 (2000), 152–158.
20. [20] Paquette, A., Shinoda, M., Rabasa-Lhoret, R., Prud'homme, D., Lavoie, J.M., Time course of liver lipid infiltration in ovariectomized rats: impact of a high-fat diet. Maturitas 58 (2007), 182–190.
21. [21] Campos, L.B., Gilglioni, E.H., Garcia, R.F., Brito, M.N., Natali, M.R., Ishii-Iwamoto, E.L., Salgueiro-Pagadigorria, C.L., Cimicifugaracemosa impairs fatty acid β-oxidation and induces oxidative stress in livers of ovariectomized rats with renovascular hypertension. Free Radic. Biol. Med. 15 (2012), 680–689.
22. [22] Gilglioni, E.H., Campos, L.B., Oliveira, M.C., Garcia, R.F., Ambiel, C.R., Buzzo, A.J., Ishii-Iwamoto, E.L., Salgueiro-Pagadigorria, C.L., Beneficial effects of tibolone on blood pressure and liver redox status in ovariectomized rats with renovascular hypertension. J. Gerontol. A. Biol. 68 (2013), 510–520.
23. [23] Moreno, F.N., Campos-Shimada, L.B., Costa, S.C., Garcia, R.F., Cecchini, A.L., Natali, M.R.M., Vitoriano, A.S., Ishii-Iwamoto, E.L., Salgueiro-Pagadigorria, C.L., Vitex agnus-castus L. (Verbenaceae) improves the liver lipid metabolism and redox state of ovariectomized rats. Evid. Based Complement. Alternat. Med., 2015, 212378 (14 p).
24. [24] Zavodnik, I.B., Lapshina, E.A., Cheshchevik, V.T., Dremza, I.K., Kujawa, J., Zabrodskaya, S.V., Reiter, R.J., Melatonin and succinate reduce rat liver mitochondrial dysfunction in diabetes. J. Physiol. Pharmacol. 62 (2011), 421–427.
25. [25] Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972), 499–502.
26. [26] Folch, J., Lees, M., Sloane-Stanley, G.H., A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957), 497–509.
27. [27] Bracht, A., Ishii-Iwamoto, E.L., Salgueiro-Pagadigorria, C.L., Técnicas de centrifugação e de fracionamento celular. Bracht, A., Ishii-Iwamoto, E.L., (eds.) Métodos de laboratório em bioquímica, 2003, Manole, São Paulo, 77–101.
28. [28] Paglia, E.D., Valentine, W.N., Studies on the quantitative and qualitative characterization of erythrocyte glutatione peroxidase. J. Lab. Clin. Med. 70 (1967), 158–169.
29. [29] Garland, P.B., Shepherd, D., Nicholls, D.G., Yates, D.W., Light, P.A., Interactions between fatty acid oxidation and the tricarboxylic acid cycle. Lowestein, J.M., (eds.) Citric Acid Cycle, 1969, Dekker, New York, 163–212.
30. [30] Chance, B., Williams, G.R., A simple and rapid assay of oxidative phosphorylation. Nature 175 (1955), 1120–1121.
31. [31] Singer, T.P., Determination of the activity of succinate, NADH, choline and glycerophosphate dehydrogenase. Methods Biochem. Anal. 22 (1974), 125–175.
32. [32] Berson, A., De Beco, V., Lettéron, P., Robin, M.A., Moreau, C., El Kahwaji, J., Verthier, N., Feldmann, G., Fromenty, B., Pessayre, D., Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 114 (1998), 764–774.
33. [33] Hissin, P.J., Hilf, R.A., Fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74 (1976), 214–226.
34. [34] Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979), 351–358.
35. [35] Guarnier, F.A., Cecchini, A.L., Suzukawa, A.A., Maragno, A.L.G.C., Simão, A.N.C., Gomes, M.D., Cecchini, R., Time course of skeletal muscle loss and oxidative stress in rats with walker 256 solid tumor. Muscle Nerve 42 (2010), 950–958.
36. [36] Dalle-donne, I., Rossi, R., Giustarini, D., Milzani, A., Colombo, R., Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 329 (2003), 23–38.
37. [37] Marklund, S., Marklund, G., Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47 (1974), 469–474.
38. [38] Aebi, H., Catalase. Bergmeyer, H.U., (eds.) Methods of Enzymatic Analysis, 1974, Academic Press, New York, 673–690.
39. [39] Mize, C.E., Langdon, R.G., Hepatic glutathione reductase. Purification and general kinetic properties. J. Biol. Chem. 237 (1962), 1589–1595.
40. [40] Tian, W.N., Pignatare, N., Stanton, R.C., Signal transduction proteins that associate with the platelet-derived growth factor (PDGF) receptor mediate the PDGF-induced release of glucose-6-phosphate dehydrogenase from permeabilized cells. J. Biol. Chem. 269 (1994), 14798–14805.
41. [41] Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951), 265–275.
42. [42] Völzke, H., Schwarz, S., Baumeister, E., Wallaschofski, H., Schwahn, C., Grabe, H.J., Kohlmann, T., John, U., Dören, M., Menopausal status and hepatic steatosis in a general female population. Gut 56 (2007), 594–595.
43. [43] Paquette, A., Wang, D., Jankowski, M., Gutkowska, J., Lavoie, J.M., Effects of ovariectomy on PPAR-α, SREBP-1c and SCD-1 gene expression in the rat liver. Menopause 15 (2008), 1169–1175.
44. [44] Foryst-Ludwig, A., Kintscher, U., Metabolic impact of estrogen signalling through ERalpha and ERbeta. J. Steroid Biochem. 122 (2010), 74–81.
45. [45] Chen, J., Brown, T.R., Russo, J., Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. BBA-Mol. Cell. Res. 1793 (2009), 1128–1143.
46. [46] D'Eon, T.M., Souza, S.C., Aronovitz, M., Obin, M.S., Fried, S.K., Greenberg, A.S., Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J. Biol. Chem. 280 (2005), 35983–35991.
47. [47] Fan, W., Evans, R., PPARs and ERRs: molecular mediators of mitochondrial metabolism. Curr. Opin. Cell Biol. 33 (2015), 49–54.
48. [48] Paul, P., Lahaye, C., Delagrange, P., Nicolas, J.P., Canet, E., Boutin, J.A., Characterization of 2-[125I]iodomelatonin binding sites in Syrian hamster peripheral organs. J. Pharmacol. Exp. Ther. 290 (1999), 334–340.
49. [49] Ishii, H., Tanaka, N., Kobayashi, M., Kato, M., Sakuma, Y., Gene structures, biochemical characterization and distribution of rat melatonin receptors. J. Physiol. Sci. 49 (2009), 37–47.
50. [50] Jablonska, K., Pula, B., Zemla, A., Kobierzycki, C., Kedzia, W., Nowak-Markwitz, E., Spaczynski, M., Zabel, M., Podhorska-Okolow, M., Dziegiel, P., Expression of the MT1 melatonin receptor in ovarian cancer cells. Int. J. Mol. Sci. 15 (2014), 23074–23089.
51. [51] Nosjean, O., Ferro, M., Coge, F., Beauverger, P., Henlin, J.M., Lefoulon, F., Fauchere, J.L., Delagrange, P., Canet, E., Boutin, J.A., Identification of the melatonin-binding site MT3 as the quinone reductase 2. J. Biol. Chem. 275 (2000), 31311–31317.
52. [52] Poon, A.M., Choy, E.H., Pang, S.F., Modulation of blood glucose by melatonin: a direct action on melatonin receptors in mouse hepatocytes. Biol. Signals Recept. 10 (2001), 367–379.
53. [53] Rodriguez, C., Mayo, J.C., Sainz, R.M., Antolín, I., Herrera, F., Martín, V., Reiter, R.J., Regulation of antioxidant enzymes: a significant role for melatonin. J. Pineal Res. 36:36 (2004), 1–9.
54. [54] Pozo, D., Reiter, R.J., Calvo, J.R., Guerrero, J.M., Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J. Cell. Biochem. 65 (1997), 430–442.
55. [55] Zhang, H., Akbar, M., Kim, H.Y., Melatonin: an endogenous negative modulator of 12-lipoxygenation in the rat pineal gland. Biochem. J. 344 (1999), 487–493.
56. [56] Guney, S.E., Cumao, A., Ozturk, G., Akbulut, K.G., Karasu, C., Comparison of melatonin effect on oxidant status and antioxidant capacity in liver and heart of young and aged rats. Int. J. Gerontol. 7 (2013), 45–49.
57. [57] Cristofanon, S., Uguccioni, F., Cerella, C., Radogna, F., Dicato, M., Ghibelli, L., Diederich, M., Intracellular prooxidant activity of melatonin induces a survival pathway involving NF-kappaB activation. Ann. N. Y. Acad. Sci. 1171 (2009), 472–478.
58. [58] Bizzarri, M., Proietti, S., Cucina, A., Reiter, R.J., Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review. Expert Opin. Ther. Targets 17 (2013), 1483–1496.
59. [59] Lambert, A.J., Brand, M.D., Reactive oxygen species production by mitochondria. Methods Mol. Biol. 554 (2009), 165–181.
60. [60] Lambert, A.J., Brand, M.D., Inhibitors of the quinone binding site allow rapid superoxide production from mitochondrial NADH: ubiquinone oxidoredutase (complex I). J. Biol. Chem. 279 (2004), 39414–39420.
61. [61] Turrens, J.F., Mitochondrial formatin of reactive oxygen species. J. Physiol. 552 (2003), 335–344.
62. [62] Mathes, A.M., Hepatoprotective actions of melatonin: possible mediation by melatonin receptors. World J. Gastroenterol. 16 (2010), 6087–6097.
63. [63] Tan, D.X., Reiter, R.J., Manchester, L.C., Yan, M.T., el-Sawi, M., Sainz, R.M., Mayo, J.C., Kohen, R., Allegra, M., Hardeland, R., Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Top. Med. Chem. 2002 (2002), 181–197.
64. [64] Hardeland, R., Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 27 (2005), 119–130.
65. [65] Farrel, G.C., Larter, C.Z., Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006), S99–S112.
66. [66] Hopps, E., Noto, D., Caimi, G., Averna, M.R.A., A novel component of metabolic syndrome: the oxidative stress. Nutr. Metab. Cardiovas. 20 (2010), 72–77.